DDI Hosts a Collaborative Event for World Obesity Day

Published on

Dasman Diabetes Institute, in cooperation with the Ministry of Health in Kuwait, Kuwait Obesity Society, and obesity-related authorities in the governmental and private sectors, organized an awareness event on the World Obesity Day, sponsored by Novo Nordisk.

Dr Ebaa Al-Ozairi, Chief Medical Officer at Dasman Diabetes Institute, talked about obesity and its associated comorbidities such as: insulin resistance, diabetes, heart disease, blood pressure, breathing problems, fatty liver disease and other possible health complications that could be avoided by prevention and proper treatment.

“Obesity is a recognized chronic relapsing serious disease with high prevalence in Kuwait. Due to this alarming situation, Novo Nordisk continues its commitment to drive change in obesity by collaborating with key stakeholders to support people living with obesity in Kuwait” said Mr. Venkat Kalyan – Vice President and General Manager, Novo Nordisk Pharma Gulf.”

Would you like to subscribe
to our newsletter?